Cours Protagenic Therapeutics, Inc. Other OTC
Actions
PTIX
US74365N1037
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 4,39 M 3,97 M |
---|---|---|---|---|---|
Résultat net 2022 | -3 M -2,71 M | Résultat net 2023 | -5 M -4,52 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 7,63 M 6,91 M | Trésorerie nette 2023 | 4,06 M 3,67 M | VE / CA 2023 | - |
PER 2022 |
-1,94
x | PER 2023 |
-0,86
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 78,17% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01/02/16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01/02/16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/02/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03/02/94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/02/16 |
Brian Corvese
BRD | Director/Board Member | 67 | 28/07/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,69% | 47,86 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,66 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+28,07% | 12,14 Md | |
+0,17% | 12,15 Md | |
-1,24% | 11,99 Md |